| 000 | 01619 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517230254.0 | ||
| 264 | 0 | _c20181102 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a1950-6007 | ||
| 024 | 7 |
_a10.1016/j.biopha.2018.03.058 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLuo, Li | |
| 245 | 0 | 0 |
_aSuppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway. _h[electronic resource] |
| 260 |
_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cSep 2018 |
||
| 300 |
_a841-847 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBleomycin _xtoxicity |
| 650 | 0 | 4 |
_aCalcium-Binding Proteins _xdeficiency |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aPulmonary Fibrosis _xchemically induced |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSmad2 Protein _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSmad3 Protein _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta1 _xantagonists & inhibitors |
| 700 | 1 | _aWang, Chang-Cheng | |
| 700 | 1 | _aSong, Xiao-Ping | |
| 700 | 1 | _aWang, Hong-Mei | |
| 700 | 1 | _aZhou, Hui | |
| 700 | 1 | _aSun, Ying | |
| 700 | 1 | _aWang, Xiao-Kun | |
| 700 | 1 | _aHou, Shuo | |
| 700 | 1 | _aPei, Fu-Yang | |
| 773 | 0 |
_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 105 _gp. 841-847 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopha.2018.03.058 _zAvailable from publisher's website |
| 999 |
_c28645306 _d28645306 |
||